BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2167302)

  • 1. Topical 8-bromo-cyclic GMP lowers intraocular pressure in rabbits.
    Becker B
    Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1647-9. PubMed ID: 2167302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical application of a cyclic GMP analog lowers IOP in normal and ocular hypertensive rabbits.
    Stein PJ; Clack JW
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2765-8. PubMed ID: 8188470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, acid-base balance and intraocular pressure effects of ethyloxaloylazolamide--a novel topically active carbonic anhydrase inhibitor.
    Sharir M; Pierce WM; Chen D; Zimmerman TJ
    Exp Eye Res; 1994 Jan; 58(1):107-16. PubMed ID: 8157096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys.
    Tokushige H; Inatani M; Nemoto S; Sakaki H; Katayama K; Uehata M; Tanihara H
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3216-22. PubMed ID: 17591891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased intraocular pressure following topical azide or nitroprusside.
    Krupin T; Weiss A; Becker B; Holmberg N; Fritz C
    Invest Ophthalmol Vis Sci; 1977 Nov; 16(11):1002-7. PubMed ID: 199556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acute morphologic changes that occur at the optic nerve head induced by medical reduction of intraocular pressure.
    Meredith SP; Swift L; Eke T; Broadway DC
    J Glaucoma; 2007 Sep; 16(6):556-61. PubMed ID: 17873718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the H-1152P, a potent Rho-associated coiled coil-formed protein kinase inhibitor, in rabbit normal and ocular hypertensive eyes.
    Nishio M; Fukunaga T; Sugimoto M; Ikesugi K; Sumi K; Hidaka H; Uji Y
    Curr Eye Res; 2009 Apr; 34(4):282-6. PubMed ID: 19373576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
    Brechue WF; Maren TH
    Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a cyclic AMP phosphodiesterase inhibitor, 8'-pivaloyloxymethyl ester of griseolic acid, on aqueous humor dynamics in rabbits.
    Kiuchi Y; Mishima HK; Araie M
    Jpn J Ophthalmol; 1991; 35(1):23-9. PubMed ID: 1654474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical control of intraocular pressure after phacoemulsification.
    Dayanir V; Ozcura F; Kir E; Topaloğlu A; Ozkan SB; Aktunç T
    J Cataract Refract Surg; 2005 Mar; 31(3):484-8. PubMed ID: 15811735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular hypotensive mechanism of intravitreally injected brain natriuretic peptide in rabbit.
    Takashima Y; Taniguchi T; Yoshida M; Haque MS; Yoshimura N; Honda Y
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2671-7. PubMed ID: 8977481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of flunarizine, a calcium channel blocker, on intraocular pressure and aqueous humor dynamics in monkeys.
    Wang RF; Gagliuso DJ; Podos SM
    J Glaucoma; 2008; 17(1):73-8. PubMed ID: 18303390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical vanadate lowers intraocular pressure in rabbits.
    Krupin T; Becker B; Podos SM
    Invest Ophthalmol Vis Sci; 1980 Nov; 19(11):1360-63. PubMed ID: 6253411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular hypotensive and aqueous outflow-enhancing effects of AL-3037A (sodium ferri ethylenediaminetetraacetate).
    Pang IH; Moll H; McLaughlin MA; Knepper PA; De Santis L; Epstein DL; Clark AF
    Exp Eye Res; 2001 Dec; 73(6):815-25. PubMed ID: 11846512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of MK-507 on aqueous humor dynamics in normal human eyes.
    Yamazaki Y; Miyamoto S; Sawa M
    Jpn J Ophthalmol; 1994; 38(1):92-6. PubMed ID: 7933704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5-HT(1A)Receptor agonist 8-OH-DPAT lowers intraocular pressure in normotensive NZW rabbits.
    Chidlow G; Nash MS; De Santis LM; Osborne NN
    Exp Eye Res; 1999 Dec; 69(6):587-93. PubMed ID: 10620387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular effects of topical administration of the phosphodiesterase III inhibitor milrinone in rabbits and cats.
    Lee KC; Silver PJ; Bode DC; Gherezghiher T
    Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):527-34. PubMed ID: 8309316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular and systemic effects of acetazolamide in nephrectomized rabbits.
    Friedman Z; Krupin T; Becker B
    Invest Ophthalmol Vis Sci; 1982 Aug; 23(2):209-13. PubMed ID: 6807936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
    Wang RF; Gagliuso DJ; Mittag TW; Podos SM
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical SDZ GLC-756, a novel dopamine D-1 antagonist and D-2 agonist, lowers intraocular pressure in conscious rabbits.
    Prünte C; Nuttli I; Markstein R
    Jpn J Ophthalmol; 1996; 40(2):167-73. PubMed ID: 8876383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.